Coherent, Inc. · COHR · FY2026 Q3 · Calendar Q2 2026

Coherent sees strong AI-optics demand as capacity expands

Coherent’s current transcript analysis supports a constructive demand-and-capacity thesis: AI data-center optics demand, backlog visibility, and the 6-inch indium phosphide ramp are supporting growth and margins. The case remains dependent on production execution, product ramps, and sustained AI infrastructure spending.

Reported After market closeNYSETechnology $57.88B market cap
90quality score

Earnings scorecard

Reported versus consensus
Reported EPS $1.41 Consensus $1.40
EPS surprise +0.7% Reported versus consensus
Reported revenue $1.81B Consensus $1.78B
Revenue surprise +1.3% Reported versus consensus

Market reaction

event-close to next-session close
Stock move -7.4% Event window
SPY move -0.3% Same window
Abnormal move -7.1% Stock minus SPY
Volume 2.1× Versus trailing sessions
Subsequent drift +18.1% Up to 20 sessions
COHRSPY benchmark

Ask FN2 about COHR FY2026 Q3

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Management highlighted an accelerated 6-inch indium phosphide expansion, a $2 billion NVIDIA equity investment and multiyear supply agreement, and an OCS opportunity revised above $4 billion after a bottleneck was removed. New OCS, CPO, multi-rail, and thermal-management contributions are expected across H2 2026 to H2 2027.

Guidance delta

Maintained; management indicated continued sequential revenue growth in Q4 and higher growth rates in FY27.

Key takeaways

  • AI data-center optics demand remains strong, with backlog orders extending to 2028.
  • The 6-inch indium phosphide ramp, pricing, and yield improvements are supporting margin expansion.
  • OCS, CPO, multi-rail, and thermal products are the main cited future growth vectors.
  • Higher Q4 capital expenditures will support capacity expansion.
  • The NVIDIA partnership adds capital and long-term supply visibility.

Management priorities

  • Expand indium phosphide capacity.
  • Scale OCS and CPO offerings.
  • Develop multi-rail systems and thermal-management products.
  • Fund growth through higher Q4 capital expenditures.
  • Support AI data-center bandwidth and energy-efficiency demand.

Follow COHR with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
COHR EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 3 future estimate-only quarters. Q3 '24 estimate $0.42 Q3 '24 actual $0.53, beat Q4 '24 estimate $0.60 Q4 '24 actual $0.61, match Q1 '25 estimate $0.61 Q1 '25 actual $0.74, beat Q4 '25 estimate $0.92 Q4 '25 actual $1.00, beat Q1 '26 estimate $1.04 Q1 '26 actual $1.16, beat Q2 '26 estimate $1.21 Q2 '26 actual $1.29, beat Q3 '26 estimate $1.40 Q3 '26 actual $1.41, match Q4 '26 estimate $1.62 Q4 '26 actual $1.74, beat Q1 '27 estimate $1.97 Q2 '27 estimate $1.97 Q3 '27 estimate $2.47
Show 1 more >

Analyst Consensus ?

ConsensusBuy31 ratings
Bullish2477.4%
Neutral722.6%
Bearish00.0%

Analyst 52W Price Targets

$278.94Current
$52Low
$213.03Average
$455High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 28, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Rosenblatt Buy BuyMaintainSep 24, 2026
Deutsche Bank Buy BuyMaintainSep 1, 2026
Needham Buy BuyMaintainAug 13, 2026
Morgan Stanley Equal Weight Equal WeightMaintainAug 13, 2026
Jefferies Buy BuyMaintainAug 13, 2026
B. Riley Securities Neutral NeutralMaintainAug 13, 2026
Raymond James Strong Buy Strong BuyMaintainJul 2, 2026
TD Cowen Buy BuyMaintainMay 7, 2026
Stifel Buy BuyMaintainMay 5, 2026
Citigroup Buy BuyMaintainApr 21, 2026
JP Morgan Overweight OverweightMaintainApr 9, 2026
Barclays Overweight OverweightMaintainMar 3, 2026
Susquehanna Positive PositiveMaintainJan 22, 2026
B of A Securities Neutral BuyDowngradeAug 14, 2025
Northland Capital Markets Outperform OutperformMaintainJun 2, 2025
Benchmark Buy BuyMaintainMay 8, 2025
Craig-Hallum Buy BuyMaintainNov 7, 2024
UBS Buy BuyMaintainAug 7, 2023
Loop Capital Buy BuyMaintainMay 11, 2023
Cowen & Co. Outperform OutperformMaintainFeb 9, 2023
William Blair Perform Market PerformMaintainOct 17, 2022
Berenberg Hold BuyDowngradeJan 21, 2021
Longbow Research Neutral BuyDowngradeNov 12, 2020
Piper Sandler Overweight OverweightMaintainMay 28, 2020
Goldman Sachs Buy NeutralUpgradeApr 24, 2020
PiperJaffray Overweight OverweightMaintainDec 20, 2019
Stifel Nicolaus Buy BuyMaintainMay 1, 2019
B. Riley FBR Neutral NeutralMaintainMay 5, 2018
Northcoast Research Buy BuyMaintainOct 25, 2016
Sidoti & Co. Buy BuyMaintainJun 15, 2015
Noble Financial Buy HoldUpgradeJan 25, 2013
Show less

Named analyst price targets

Upside is calculated against the persisted current price $278.94. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Deutsche BankAnalyst unavailable$400$277.83 +43.4%Aug 31, 2026
Stifel NicolausRuben Roy$420$337.34 +50.6%Aug 13, 2026
Raymond JamesAnalyst unavailable$448$348.88 +60.6%Aug 13, 2026
NeedhamRyan Koontz$420$355.64 +50.6%Aug 13, 2026
JefferiesAnalyst unavailable$420$355.64 +50.6%Aug 13, 2026
Raymond JamesAnalyst unavailable$435$368.65 +56.0%Jul 2, 2026
Morgan StanleyMeta Marshall$330$326 +18.3%May 7, 2026
Northland SecuritiesAnalyst unavailable$230$323.58 -17.5%May 7, 2026
Raymond JamesAnalyst unavailable$371$329.34 +33.0%May 7, 2026
Stifel NicolausAnalyst unavailable$412$329.89 +47.7%May 5, 2026
Redburn PartnersMike Harrison$455$319.71 +63.1%May 1, 2026
Morgan StanleyAnalyst unavailable$290$341.73 +4.0%Apr 20, 2026
Morgan StanleyMeta Marshall$250$248.18 -10.4%Feb 23, 2026
Northland SecuritiesTim Savageaux$170$204.12 -39.1%Feb 5, 2026
Stifel NicolausAnalyst unavailable$235$198.78 -15.8%Feb 5, 2026
BarclaysTom O'Malley$235$211 -15.8%Feb 5, 2026
Morgan StanleyMeta Marshall$190$228.51 -31.9%Jan 30, 2026
Stifel NicolausRuben Roy$220$197.26 -21.1%Jan 22, 2026
SusquehannaChristopher Rolland$235$197.26 -15.8%Jan 22, 2026
BarclaysTom O'Malley$215$184.11 -22.9%Jan 15, 2026
Morgan StanleyMeta Marshall$180$175.2 -35.5%Dec 17, 2025
Raymond JamesSimon Leopold$210$177.35 -24.7%Dec 5, 2025
NeedhamAnalyst unavailable$190$155.44 -31.9%Nov 6, 2025
SusquehannaAnalyst unavailable$160$155.44 -42.6%Nov 6, 2025
Morgan StanleyMeta Marshall$150$155.44 -46.2%Nov 6, 2025
SusquehannaChristopher Rolland$150$120.79 -46.2%Oct 22, 2025
BarclaysTom O'Malley$135$116.35 -51.6%Oct 20, 2025
Morgan StanleyAnalyst unavailable$120$122.35 -57.0%Oct 10, 2025
BarclaysTom O'Malley$110$114.01 -60.6%Aug 14, 2025
Morgan StanleyAnalyst unavailable$97$106.74 -65.2%Aug 4, 2025
Northland SecuritiesTim Savageaux$85$76.78 -69.5%Jun 2, 2025
Raymond JamesStrong Buy$91$76.71 -67.4%Mar 24, 2025
Loop Capital MarketsAnanda Baruah$120$93 -57.0%Nov 7, 2024
Rosenblatt SecuritiesMike Genovese$105$98.44 -62.4%Oct 22, 2024
B.Riley FinancialDave Kang$86$102.07 -69.2%Oct 18, 2024
NeedhamJames Ricchiuti$120$104.62 -57.0%Oct 14, 2024
Bank of America SecuritiesVivek Arya$108$94.27 -61.3%Oct 4, 2024
SusquehannaChristopher Rolland$120$88.91 -57.0%Oct 1, 2024
Craig-HallumRichard Shannon$85$74.39 -69.5%Aug 16, 2024
NeedhamJames Ricchiuti$84$73.96 -69.9%Aug 16, 2024
Rosenblatt SecuritiesMike Genovese$84$74.05 -69.9%Aug 16, 2024
NeedhamAlex Henderson$70$71.53 -74.9%Aug 15, 2024
Bank of America SecuritiesVivek Arya$75$66.7 -73.1%Aug 12, 2024
B.Riley FinancialDave Kang$77$60.62 -72.4%Apr 1, 2024
NeedhamJames Ricchiuti$72$60.62 -74.2%Apr 1, 2024
BarclaysTom O'Malley$60$45.16 -78.5%Jan 16, 2024
NeedhamJim Ricchiuti$52$43.46 -81.4%Dec 15, 2023
NeedhamJames Ricchiuti$50$34.79 -82.1%Oct 11, 2023
NeedhamJim Ricchiuti$64$54.74 -77.1%Jun 20, 2023
Morgan StanleyAnalyst unavailable$45$35.41 -83.9%Dec 13, 2022
Deutsche BankAnalyst unavailable$50$36.82 -82.1%Nov 28, 2022
BarclaysThomas O'Malley$65$71.55 -76.7%Jan 12, 2022
Bank of America SecuritiesVivek Arya$80$71.24 -71.3%Jan 10, 2022
Craig-HallumRichard Shannon$100$74.49 -64.1%Jan 4, 2022
Morgan StanleyMeta Marshall$82$70.5 -70.6%Dec 15, 2021
Cowen & Co.Paul Silverstein$94$66.57 -66.3%Dec 13, 2021
Northland SecuritiesTim Savageaux$75$64 -73.1%Nov 10, 2021
Deutsche BankSidney Ho$75$62.66 -73.1%Sep 1, 2021
Stifel NicolausJohn Marchetti$82$64.38 -70.6%Aug 11, 2021
Show less

Track every rating change on COHR the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Coherent, Inc. specializes in advanced laser technologies, offering a comprehensive suite of products that includes lasers, laser-based solutions, and complete systems. These are deployed across a spectrum of uses, from commercial and industrial operations to critical scientific research. The company's operations are distinctly segmented into two primary areas: laser sources for Original Equipment Manufacturers (OEMs) and industrial lasers alongside integrated systems. Coherent handles the entire lifecycle of its offerings, from conceptual design and manufacturing to global marketing and ongoing service.…

Historical context

All COHR earnings

Technology peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the COHR recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
  3. Polygon adjusted daily market bars · 2026-09-28T14:30:57.484478+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-28T14:30:57.481373+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-09-28. For educational purposes only; not investment advice.